COVID-19

Your central place to rapidly access latest news, translated guidance information, and expert interpretations from our former regulators related to COVID-19. Parexel’s 1000+ consulting experts are closely following agency announcements and new guidances and can help provide deep expertise and experience in the race to bring this outbreak to a close. We’re here to fight this with you.

  • COVID-19 weekly Health Authority updates

    COVID-19 weekly Health Authority updates

    Updated every day, in a single source

    View Now
  • The Special Approval Pathway (SAP) for COVID-19 related products in China

    The Special Approval Pathway (SAP) for COVID-19 related products in China

    The regulatory pathway for COVID-19 drugs in China is governed by the Special Approval Program (SAP) which was introduced by National Medical Product Administration (NMPA) in 2005.  SAP is...

    Learn More
  • See Parexel's latest COVID-19 expert content

    View all
  • Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

    Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

    Key Takeaways The COVID-19 pandemic has drawn attention to international efforts to promote...

    Learn More
  • International Safe Abortion Day

    International Safe Abortion Day

    HRP works towards the prevention of unsafe abortion in the context of COVID-19.During the current pandemic, International Safe Abortion Day is a timely reminder that access to legal and safe...

    Learn More
  • Visit Parexel's COVID 19 Clearinghouse

    Visit Now
  • COVID-19 pandemic: countries urged to take stronger action to stop spread of harmful information

    COVID-19 pandemic: countries urged to take stronger action to stop spread of harmful information

    The World Health Organization (WHO) together with the UN, specialised agencies and partners today called on countries to develop and implement action plans to promote the timely dissemination of...

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup September 25, 2020

    Coronavirus (COVID-19) Update: Daily Roundup September 25, 2020

    FDA issues an updated summary of the agency’s COVID-19 response efforts.

    Learn More
  • UNGA Virtual high-level side event on mitigating the impact of COVID-19

    UNGA Virtual high-level side event on mitigating the impact of COVID-19

    Stewart Simonson, Assistant Director-General, WUN, moderated a high-level event hosted by the Co-Chairs of the Group of Friends of Solidarity for Global Health Security on Protraction of the...

    Learn More
  • Conflict, climate crisis and COVID-19 pose great threats to the health of women and children

    Conflict, climate crisis and COVID-19 pose great threats to the health of women and children

    25 September 2020 – Fragile gains made to advance women and children’s health are threatened by conflict, the climate crisis and COVID-19, according to a new report from Every Woman Every...

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup September 24, 2020

    Coronavirus (COVID-19) Update: Daily Roundup September 24, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • The impact of COVID-19 on clinical trials in rare disease and oncology

    The impact of COVID-19 on clinical trials in rare disease and oncology

    Learn More
  • Coronavirus (COVID-19) Update: FDA Authorizes First Point-of-Care Antibody Test for COVID-19

    Coronavirus (COVID-19) Update: FDA Authorizes First Point-of-Care Antibody Test for COVID-19

    Today, the FDA issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19.

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup September 23, 2020

    Coronavirus (COVID-19) Update: Daily Roundup September 23, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • Managing the COVID-19 infodemic: Promoting healthy behaviours and mitigating the harm from misinformation and disinformation

    The Coronavirus disease (COVID-19) is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected....

    Learn More
  • Community Health Workers and Covid-19 — Addressing Social Determinants of Health in Times of Crisis and Beyond

    New England Journal of Medicine, Ahead of Print.

    Learn More
  • Loss of Anti–SARS-CoV-2 Antibodies in Mild Covid-19

    New England Journal of Medicine, Ahead of Print.

    Learn More
  • Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust

    New England Journal of Medicine, Ahead of Print.

    Learn More
  • Ebola Response Priorities in the Time of Covid-19

    New England Journal of Medicine, Volume 383, Issue 13, Page 1202-1204, September 2020.

    Learn More
  • Audio Interview: Eight Months of Action and Inaction against Covid-19

    New England Journal of Medicine, Volume 383, Issue 13, September 2020.

    Learn More
  • Coronavirus (COVID-19) Update: Daily Roundup September 21, 2020

    Coronavirus (COVID-19) Update: Daily Roundup September 21, 2020

    FDA’s actions on a new video for consumers and an updated guidance in its ongoing response to the COVID-19 pandemic.

    Learn More
  • Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX facility

    64 higher income economies have now joined the COVAX Facility, with a further 38 economies expected to sign in the coming days These self-financing economies, which include 29 from ‘Team Europe’...

    Learn More
  • loading
    Loading More...